바로가기메뉴

본문 바로가기 주메뉴 바로가기

Tuberculosis & Respiratory Diseases

Article Contents

Prev Next
e-Submission

Vol.84 No.1
Citation Share

Importance of Public-Private Mix Collaboration in Tuberculosis Control: It Is Also Valuable in Patients with Multidrug-Resistant Tuberculosis

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2021, v.84 no.1, pp.85-86
https://doi.org/10.4046/trd.2020.0152

(2021). Importance of Public-Private Mix Collaboration in Tuberculosis Control: It Is Also Valuable in Patients with Multidrug-Resistant Tuberculosis. Tuberculosis & Respiratory Diseases, 84(1), 85-86, https://doi.org/10.4046/trd.2020.0152
  • Downloaded
  • Viewed
PDF Download

Abstract

keywords

Reference

1.

1. World Health Organization. Global tuberculosis report 2019 [Internet]. Geneva: World Health Organization; 2019[cited 2020 Jul 31]. Available from: https://apps.who.int/iris/bitstream/handle/10665/329368/9789241565714-eng. pdf?ua=1.

2.

2. Keshavjee S, Farmer PE. Tuberculosis, drug resistance, and the history of modern medicine. N Engl J Med 2012;367:931-6.

3.

3. Jeon D. Medical management of drug-resistant tuberculosis. Tuberc Respir Dis 2015;78:168-74.

4.

4. Korea Centers for Disease Control and Prevention. Annual report on the notified tuberculosis patients in Korea 2019 [Internet]. Cheongwon: Korea Centers for Disease Control and Prevention; 2020 [cited 2020 Nov 24]. Available from: http://tbzero.cdc.go.kr/tbzero/board/boardView.do.

5.

5. Kim DH, Kim HJ, Park SK, Kong SJ, Kim YS, Kim TH, et al. Treatment outcomes and long-term survival in patients with extensively drug-resistant tuberculosis. Am J Respir Crit Care Med 2008;178:1075-82.

6.

6. Go U, Park M, Kim UN, Lee S, Han S, Lee J, et al. Tuberculosis prevention and care in Korea: evolution of policy and practice. J Clin Tuberc Other Mycobact Dis 2018;11:28-36.

7.

7. Kang Y, Jo EJ, Eom JS, Kim MH, Lee K, Kim aKU, et al. Treatment outcomes of patients with multidrug-resistant tuberculosis: comparison of pre- and post-public-private mix periods. Tuberc Respir Dis 2021;84.

8.

8. Ottmani SE, Zignol M, Bencheikh N, Laasri L, Chaouki N, Mahjour J. Results of cohort analysis by category of tuberculosis retreatment cases in Morocco from 1996 to 2003. Int J Tuberc Lung Dis 2006;10:1367-72.

9.

9. Gler MT, Macalintal LE, Raymond L, Guilatco R, Quelapio MI, Tupasi TE. Multidrug-resistant tuberculosis among previously treated patients in the Philippines. Int J Tuberc Lung Dis 2011;15:652-6.

10.

10. Kolappan C, Subramani R, Kumaraswami V, Santha T, Narayanan PR. Excess mortality and risk factors for mortality among a cohort of TB patients from rural south India. Int J Tuberc Lung Dis 2008;12:81-6.

11.

11. Jeon D. WHO treatment guidelines for drug-resistant tuberculosis, 2016 update: applicability in South Korea. Tuberc Respir Dis 2017;80:336-43.

Tuberculosis & Respiratory Diseases

e-Submission OA Policy